Mako well-funded for 2020 drilling program

|

Published 12-DEC-2019 11:22 A.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Mako Gold Limited (ASX:MKG) has received firm commitments for a $680,000 placement of shares from sophisticated, professional and institutional investors to further support the company’s January step-out drilling at the Napie (Tchaga) project in Côte d'Ivoire.

The placement price of 7 cents per new share represents a 9% discount to Mako’s last closing share price of 7.7 cents.

Subscribers to the placement will also be issued with one 10 cent option expiring November 30, 2020 for every five shares issued.

This leaves the company well-funded for its planned high-impact drilling program in early 2020, building on its recent exceptional results at Tchaga.

One of the most promising results received throughout 2019 came to hand at the start of December as the company announced that one of the holes drilled at the Tchaga prospect returned 36 metres at 3.1 g/t gold.

Promising results earlier in the year included 28 metres at 4.9 g/t gold and 18 metres at 3.3 g/t gold.

Focusing on 1.4 kilometre strike length

Mako has outlined significant wide zones of gold mineralisation at the Tchaga Prospect over a 1.4 kilometre strike length.

Infill drilling will tighten up some of the widely spaced drilled areas to help progress the project towards a JORC Inferred Resource.

Funds will also be used for further drilling, exploration planning, funding the costs of the raising and to provide additional working capital.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X